- Home
- CRBU vs AZ Comparison
CRBU vs AZ Comparison
Compare CRBU & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRBU | AZ |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.9M | 224.3M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRBU | AZ |
|---|---|---|
| Price | $1.91 | $6.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $9.33 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 1.3M | 465.8K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,295,000.00 | $7,463,000.00 |
| Revenue This Year | N/A | $1,343,857.60 |
| Revenue Next Year | $4.96 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 41.45 |
| 52 Week Low | $0.66 | $5.00 |
| 52 Week High | $3.54 | $12.36 |
Technical Indicators
Market Signals| Indicator | CRBU | AZ |
|---|---|---|
| Relative Strength Index (RSI) | 45.15 | 50.79 |
| Support Level | $1.75 | $6.04 |
| Resistance Level | $1.97 | $7.23 |
| Average True Range (ATR) | 0.12 | 0.53 |
| MACD | 0.02 | 0.15 |
| Stochastic Oscillator | 66.20 | 64.39 |
Price Performance
Historical ComparisonAbout CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.